Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 11
Submit an article Journal homepage
102
Views
4
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

After the failure of citalopram for depression, what next?

RUSH AJ, TRIVEDI MH, WISNIEWSKI SR et al.: Bupriopion-SR, sertaline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1231-1242 and TRIVEDI MH, FAVA M, WISNIEWSKI SR et al.: Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1243-1252.

Sheila A Doggrell Senior Lecturer in Pharmacology, School of Science, Charles Darwin University, Casuarina, Northern Territory 0811, Australia. [email protected]
Pages 1515-1518 | Published online: 21 Jul 2006

Bibliography

  • REIMHERR FW, CUNNINGHAM LA, BATEY SR, JOHNSTON JA, ASCER JA: A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin. Ther. (1998) 20:505-516.
  • JOFFE RT, SCHULLER DR: An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J. Clin. Psychiatry (1993) 54:269-271.
  • TRIVEDI MH, RUSH AJ, WISNIEWSKI SR et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry (2006) 163:28-40.
  • RUSH AJ, TRIVEDI MH, WISNIEWSKI SR et al.: Bupriopion-SR, sertaline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1231-1242.
  • TRIVEDI MH, FAVA M, WISNIEWSKI SR et al.: Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. (2006) 354:1243-1252.
  • RUDOLPH RL, FEIGER AD: A double-blind, randomized, placebo-controlled trial of once-daily venlafazine extended release (XR) and fluoxetine for the treatment of depression. J. Affect. Disord. (1999) 56:171-181.
  • FABRE LF, ABUZZAHAB FS, AMIN JL et al.: Sertaline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Boil. Psychiatry (1995) 38:592-602
  • FABRE LF: Buspirone in the management of major depression: a placebo-controlled comparison. J. Clin. Psychiatry (1990) 51(Suppl.):55-61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.